| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0069-0305 | Trazimera | trastuzumab-qyyp | Pfizer Laboratories Div Pfizer Inc | KIT | 2020-02-24 | |
| 0069-0308 | Trazimera | trastuzumab-qyyp | Pfizer Laboratories Div Pfizer Inc | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2021-03-10 | |
| 50242-077 | Herceptin Hylecta | Trastuzumab and hyaluronidase-oysk | Genentech, Inc. | INJECTION, SOLUTION | 2019-02-28 | |
| 50242-132 | Herceptin | Trastuzumab | Genentech, Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2017-02-10 | |
| 50242-145 | PERJETA | Pertuzumab | Genentech, Inc. | INJECTION, SOLUTION, CONCENTRATE | 2012-06-08 | |
| 50242-245 | Phesgo | pertuzumab, trastuzumab, and hyaluronidase-zzxf | Genentech, Inc. | INJECTION, SOLUTION | 2020-06-29 | |
| 50242-260 | Phesgo | pertuzumab, trastuzumab, and hyaluronidase-zzxf | Genentech, Inc. | INJECTION, SOLUTION | 2020-06-29 | |
| 55513-132 | Kanjinti | trastuzumab-anns | Amgen, Inc | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2019-06-11 | |
| 55513-141 | Kanjinti | trastuzumab-anns | Amgen, Inc | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2019-10-28 | |
| 63459-303 | HERZUMA | TRASTUZUMAB | Cephalon, Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2020-03-16 | |
| 63459-305 | HERZUMA | TRASTUZUMAB | Cephalon, Inc. | KIT | 2020-03-16 | |
| 69448-015 | HERCESSI | trastuzumab-strf | Accord BioPharma Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2025-01-01 | |
| 69448-016 | HERCESSI | trastuzumab-strf | Accord BioPharma Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2025-01-01 | |
| 70720-022 | MARGENZA | margetuximab-cmkb | TerSera Therapeutics LLC | INJECTION, SOLUTION, CONCENTRATE | 2021-01-15 | |
| 74527-022 | MARGENZA | margetuximab-cmkb | MacroGenics, Inc | INJECTION, SOLUTION, CONCENTRATE | 2021-01-15 | |
| 78206-147 | Ontruzant | trastuzumab | Organon LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2021-06-01 | |
| 78206-148 | Ontruzant | Ontruzant | Organon LLC | KIT | 2021-06-01 | |
| 83257-001 | OGIVRI | trastuzumab-dkst | Biocon Biologics Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2023-10-01 | |
| 83257-003 | OGIVRI | trastuzumab-dkst | Biocon Biologics Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2023-10-01 | |
| 83257-004 | OGIVRI | trastuzumab-dkst | Biocon Biologics Inc. | KIT | 2023-10-01 |
Loading full table content...